The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
400 jobs Number of planned job creations
Announcement Date
27 August 2020
Employment effect (start)
27 August 2020
Foreseen end date
Description
Biopharma pharmaceutical company Regeneron is to create 400 new jobs at its plant in Limerick.
The new roles are in commercial manufacturing, process sciences, quality assurance/control, supply chain and various support functions for scientists, chemists and technicians.
Regeneron already employs around 1,000 people in Ireland. The company, operating in Ireland since 2015, has invested over €850m to make its manufacturing plant, the former Dell company site, the largest bulk biologics facility in Ireland.
The company is also involved in developing treatment for COVID-19.
Eurofound (2020), Regeneron, Business expansion in Ireland, factsheet number 101554, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/101554.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
